New Zealand vs United States: Proportion of isolates with decreased susceptibility or resistance
New Zealand
0.4386
in 2017
United States
0.2907
in 2018
New Zealand rank
22nd
United States rank
23rd
Proportion of isolates with decreased susceptibility or resistance over time
- New Zealand
- United States
How they compare
New Zealand currently reports 0.4386 against 0.2907 in United States, a difference of 0.1479.
That makes New Zealand's figure about 1.5 times United States's.
The two have swapped places 5 times across 9 shared years of data; in 2009 it was United States ahead.
New Zealand ranks 22nd and United States ranks 23rd of 51 countries.
United States has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | New Zealand | United States | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0 | 0.7993 | 0.7993 | United States |
| 2010s | 0.3595 | 0.4231 | 0.0635 | United States |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of isolates with decreased susceptibility or resistance, New Zealand or United States?
- New Zealand, at 0.4386 against 0.2907 in United States as of 2017.
- What is the difference in proportion of isolates with decreased susceptibility or resistance between New Zealand and United States?
- 0.1479, with New Zealand ahead.
- How many years of comparable data are there for New Zealand and United States?
- 9 years are reported by both, from 2009 to 2017.
- How do New Zealand and United States rank globally for proportion of isolates with decreased susceptibility or resistance?
- New Zealand ranks 22nd and United States ranks 23rd of 51 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Proportion of isolates with decreased susceptibility or resistance (DS/R) to extended-spectrum cephalosporins reported to WHO-GASP. Statizoid refreshes it automatically from the source and publishes the full history for both places.